Stanton Glantz, Professor of Medicine and Director of the Center for Tobacco Control Research and Education at the University of California San Francisco, is fabricating more false claims regarding the dual use of both e-cigarettes and ecigs for years. Members of the University of California San Fransisco picked up from his work to craft their own counterintuitive warnings.
Now, a paper in Nicotine & Tobacco research concludes that vaping contributes minimally to toxicant biomarkers.
In 2019, Glantz claimed “the data is catching up with public perception”, in that vaping presents an increased risk to dual use smokers due to “an aerosol of ultrafine particles and other toxicants that carry substantial health risks”.
Researchers at the University of California found that vaping in dual-use users caused “adverse pulmonary and cardiovascular health symptoms/conditions”. This was brought about by manipulating the data, just so they could say that “many smokers are adopting e-cigarettes for smoking cessation, which warrants effective strategies to help dual users wean off both cigarettes and e-cigarettes.”
This argument is clearly problematic, after all. It isn’t possible for something such as vaping to be both at least 95% safer than smoking, while also increasing risk when substituting for cigarettes?
According to a team of American researchers and FDA officials, the answer is a resounding no. Using the Population Assessment of Tobacco and Health (PATH) data revered in Californian circles, the group published their findings in Nicotine & Tobacco Research.
They compared dual users on demographic, behavioural, and biomarker measures with exclusive cigarette smokers and exclusive e-cigarette users.
They found, “most dual users were predominant cigarette smokers (70%), followed by daily dual users (13%), non-daily concurrent dual users (10%), and predominant vapers (7%).”
- Dual users who smoked daily showed significantly higher biomarker concentrations compared with those who did not smoke daily
- Patterns of e-cigarette use had little effect on toxicant exposure
- Dual users with high toxicant exposure were generally older, female, and smoked more cigarettes per day
- Dual users who had low levels of biomarkers of exposure were generally younger, male, and smoked non-daily
Not only does the study and research prove once again that vaping is a much safer alternative to smoking, but it also completely destroy the Californian arguments that vaping increases risks for current smokers.